Related Experiment Video
Updated: May 10, 2026
08:56
Transient Expression in Nicotiana Benthamiana Leaves for Triterpene Production at a Preparative Scale
Published on: August 16, 2018
18.2K
ent-Abietane Diterpenoids From Phlogacanthus curviflorus
Ren-Fen Ma1,2, Qian Wu2, Hua Zhang2
1School of Chemistry and Chemical Engineering, University of Jinan, Jinan, China.
Chemistry & Biodiversity
|February 24, 2026
Summary
Researchers isolated novel compounds from Phlogacanthus curviflorus, with one showing significant inhibition against the diabetes target alpha-glucosidase (α-glucosidase). Further studies are needed to explore potential therapeutic applications.
Area of Science:
- Natural Product Chemistry
- Pharmacology
- Medicinal Chemistry
Background:
- Phlogacanthus curviflorus is an ethnological herb with potential medicinal properties.
- Diterpenoids, including ent-abietanes, are a class of natural products known for diverse bioactivities.
Purpose of the Study:
- To isolate and characterize novel ent-abietane diterpenoids from Phlogacanthus curviflorus.
- To evaluate the isolated compounds for inhibitory activity against α-glucosidase and cytotoxicity against human tumor cell lines.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation utilizing High-Resolution Electrospray Ionization Mass Spectrometry (HR-ESIMS), Nuclear Magnetic Resonance (NMR), Electronic Circular Dichroism (ECD), and X-ray crystallography.
- Enzyme inhibition assays for α-glucosidase and cytotoxicity assays against MDA-MB-231, HeLa, and A549 cell lines.
Main Results:
- Eight new ent-abietanes (four nor-diterpenoids, two intact diterpenoids, and two pairs of equilibrium isomers) and six known analogues were isolated.
- Compound 1 demonstrated significant α-glucosidase inhibitory activity with an IC50 value of 19.06 ± 1.47 µM.
- None of the isolated compounds exhibited significant cytotoxicity against the tested human tumor cell lines.
Conclusions:
- The study successfully identified novel ent-abietane diterpenoids from Phlogacanthus curviflorus.
- Compound 1 shows promise as a potential therapeutic agent for type 2 diabetes due to its α-glucosidase inhibitory effect.
- The lack of cytotoxicity suggests a favorable safety profile for further investigation.
